Its announcement arrives on the heels of a similar licensing arrangement available in February to Adastra Labs, which experienced until now centered on crafting cannabis extracts. Adastra's license also permits it to create and provide psilocybin and psilocin – hallucinogens extra normally often known as magic mushrooms that produce consequences